These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 29373835

  • 1. The in vitro detection of botulinum neurotoxin-cleaved endogenous VAMP is epitope-dependent.
    Gray B, Cadd V, Elliott M, Beard M.
    Toxicol In Vitro; 2018 Apr; 48():255-261. PubMed ID: 29373835
    [Abstract] [Full Text] [Related]

  • 2. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
    Chen S, Hall C, Barbieri JT.
    J Biol Chem; 2008 Jul 25; 283(30):21153-9. PubMed ID: 18511417
    [Abstract] [Full Text] [Related]

  • 3. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW, Chai Q, Christian T, Stevens RC.
    Biochemistry; 2006 Mar 14; 45(10):3255-62. PubMed ID: 16519520
    [Abstract] [Full Text] [Related]

  • 4. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 5. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
    Foran P, Shone CC, Dolly JO.
    Biochemistry; 1994 Dec 27; 33(51):15365-74. PubMed ID: 7803399
    [Abstract] [Full Text] [Related]

  • 6. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
    Sikorra S, Henke T, Galli T, Binz T.
    J Biol Chem; 2008 Jul 25; 283(30):21145-52. PubMed ID: 18511418
    [Abstract] [Full Text] [Related]

  • 7. Synaptic vesicle chips to assay botulinum neurotoxins.
    Ferracci G, Miquelis R, Kozaki S, Seagar M, Lévêque C.
    Biochem J; 2005 Nov 01; 391(Pt 3):659-66. PubMed ID: 16011482
    [Abstract] [Full Text] [Related]

  • 8. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.
    Sikorra S, Henke T, Swaminathan S, Galli T, Binz T.
    J Mol Biol; 2006 Mar 24; 357(2):574-82. PubMed ID: 16430921
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of a novel botulinum neurotoxin.
    Zhang S, Masuyer G, Zhang J, Shen Y, Lundin D, Henriksson L, Miyashita SI, Martínez-Carranza M, Dong M, Stenmark P.
    Nat Commun; 2017 Aug 03; 8():14130. PubMed ID: 28770820
    [Abstract] [Full Text] [Related]

  • 10. Activity of botulinum neurotoxin type D (strain 1873) in human neurons.
    Pellett S, Tepp WH, Scherf JM, Pier CL, Johnson EA.
    Toxicon; 2015 Jul 03; 101():63-9. PubMed ID: 25937339
    [Abstract] [Full Text] [Related]

  • 11. High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.
    Carle S, Pirazzini M, Rossetto O, Barth H, Montecucco C.
    Toxins (Basel); 2017 Dec 19; 9(12):. PubMed ID: 29257047
    [Abstract] [Full Text] [Related]

  • 12. Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody.
    Fabris F, Šoštarić P, Matak I, Binz T, Toffan A, Simonato M, Montecucco C, Pirazzini M, Rossetto O.
    Int J Mol Sci; 2022 Apr 14; 23(8):. PubMed ID: 35457172
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.
    Elliott M, Maignel J, Liu SM, Favre-Guilmard C, Mir I, Farrow P, Hornby F, Marlin S, Palan S, Beard M, Krupp J.
    PLoS One; 2017 Apr 14; 12(10):e0185628. PubMed ID: 28982136
    [Abstract] [Full Text] [Related]

  • 14. Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments.
    von Berg L, Stern D, Weisemann J, Rummel A, Dorner MB, Dorner BG.
    Toxins (Basel); 2019 Oct 11; 11(10):. PubMed ID: 31614566
    [Abstract] [Full Text] [Related]

  • 15. A protein chip membrane-capture assay for botulinum neurotoxin activity.
    Marconi S, Ferracci G, Berthomieu M, Kozaki S, Miquelis R, Boucraut J, Seagar M, Lévêque C.
    Toxicol Appl Pharmacol; 2008 Dec 15; 233(3):439-46. PubMed ID: 18845174
    [Abstract] [Full Text] [Related]

  • 16. Structure and function of tetanus and botulinum neurotoxins.
    Montecucco C, Schiavo G.
    Q Rev Biophys; 1995 Nov 15; 28(4):423-72. PubMed ID: 8771234
    [Abstract] [Full Text] [Related]

  • 17. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
    Kalb SR, Baudys J, Raphael BH, Dykes JK, Lúquez C, Maslanka SE, Barr JR.
    Anal Chem; 2015 Apr 07; 87(7):3911-7. PubMed ID: 25731972
    [Abstract] [Full Text] [Related]

  • 18. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
    Shone CC, Roberts AK.
    Eur J Biochem; 1994 Oct 01; 225(1):263-70. PubMed ID: 7925446
    [Abstract] [Full Text] [Related]

  • 19. Botulinum and Tetanus Neurotoxin-Induced Blockade of Synaptic Transmission in Networked Cultures of Human and Rodent Neurons.
    Beske PH, Bradford AB, Grynovicki JO, Glotfelty EJ, Hoffman KM, Hubbard KS, Tuznik KM, McNutt PM.
    Toxicol Sci; 2016 Feb 01; 149(2):503-15. PubMed ID: 26615023
    [Abstract] [Full Text] [Related]

  • 20. Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.
    Purkiss JR, Friis LM, Doward S, Quinn CP.
    Neurotoxicology; 2001 Aug 01; 22(4):447-53. PubMed ID: 11577803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.